Mankind Pharma gets DRDO nod to manufacture, market COVID drug 2-DG

2-DG was developed by the Defence Research and Development Establishment (DRDE), Gwalior. The clinical trials were conducted by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of DRDO, in association with Dr Reddy’s Laboratories, Mankind Pharma said in a statement.

Original source: https://health.economictimes.indiatimes.com/news/pharma/84235645?utm_source=RSS&utm_medium=ETRSS

Related Posts